SCHEMBL19768142

SCHEMBL19768142

c1cc(-c2cnccn2)cc(-c2ccc3ccc4ccc(-c5ccc6ccccc6c5)nc4c3n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.53
CYP11B2 P19099 5/20 0.53
CYP19A1 P11511 2/20 0.53
CYP17A1 P05093 1/20 0.53
SIRT2 Q8IXJ6 6/20 0.51
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ABL1 P00519 1/20 0.42
PIM2 Q9P1W9 2/20 0.41
PIM1 P11309 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PI4KA P42356 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
CYP2A6 P11509 1/20 0.39
GRK6 P43250 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4144929 0.87 CYP11B1 (0.58) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL19768302 0.86 CYP11B2 (0.73) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL10032275 0.85 CYP1A1 (0.51) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL10032315 0.83 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL19768144 0.83 CYP11B1 (0.51) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL19768149 0.82 ALOX5AP (0.37) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL24475262 0.82 CYP1A1 (0.57) CYP11B1CYP11B2CYP19A1CYP17A1NPC1
SCHEMBL19768100 0.81 SIRT2 (0.47) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL19768049 0.81 CYP11B1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2
SCHEMBL19768254 0.81 CYP17A1 (0.53) CYP11B1CYP11B2CYP19A1CYP17A1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 CYP11B1 1041/4885CYP11B2 472/4885CYP19A1 1636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.